• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髓母细胞瘤中生存素的表达:一种可能的生存标志物。

Survivin expression in medulloblastoma: a possible marker for survival.

机构信息

Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

出版信息

Pathol Oncol Res. 2013 Jul;19(3):413-9. doi: 10.1007/s12253-012-9594-9. Epub 2012 Dec 16.

DOI:10.1007/s12253-012-9594-9
PMID:23242569
Abstract

UNLABELLED

Medulloblastomas are highly invasive tumors which are generally disseminated at the time of diagnosis. High and continued morbidity and mortality have prompted the search for new biologic markers that might be used for targeted therapy to minimise treatment related side effects. In this work, we studied the positive expression of survivin in medulloblastoma and investigated its relation to clinical, pathologic data and survival. Tumor tissue specimens from 47 patients with medulloblastoma who underwent primary surgical treatment from June 2002 to June 2006 at the Mansoura university hospital, Egypt were collected. Paraffin sections of all samples were submitted for immunohistochemistry using anti-survivin antibody. The relation between the percentage of positive survivin cells with clinical, pathological and survival data was evaluated.

RESULTS

In 47 cancer tissue specimens, one case large-cell-anaplastic (1.12 %), tweleve cases desmoplastic (25.53 %) and 34 cases classic medulloblastomas (72.34 %). The immunohistochemical expression of survivin was nulear with moderate intensity. It does not correlate with either age or sex. There was a significant negative correlation of survivin expression with survival (p < 0.001), where negative survivin immunostaining was associated with prolonged overall and disease free survival, while survivin expression was associated with shortened survival.

CONCLUSION

Survivin expression correlate with the clinical outcome with poor prognosis and could be a potential predictive factor for recurrence or metastasis.

摘要

未标记

成神经管细胞瘤是高度侵袭性肿瘤,通常在诊断时就已扩散。高且持续的发病率和死亡率促使人们寻找新的生物标志物,以便进行靶向治疗,从而最大限度地减少治疗相关的副作用。在这项工作中,我们研究了成神经管细胞瘤中 survivin 的阳性表达,并研究了其与临床、病理数据和生存的关系。从 2002 年 6 月至 2006 年 6 月,在埃及曼苏拉大学医院接受初次手术治疗的 47 例成神经管细胞瘤患者的肿瘤组织标本被收集。所有样本的石蜡切片均使用抗 survivin 抗体进行免疫组织化学染色。评估了阳性 survivin 细胞的百分比与临床、病理和生存数据之间的关系。

结果

在 47 例癌症组织标本中,1 例大细胞-间变性(1.12%),12 例促结缔组织增生性(25.53%)和 34 例经典成神经管细胞瘤(72.34%)。 survivin 的免疫组织化学表达为核中等强度。它与年龄或性别无关。 survivin 表达与生存呈显著负相关(p<0.001),其中 survivin 免疫染色阴性与总生存期和无病生存期延长相关,而 survivin 表达与生存期缩短相关。

结论

survivin 表达与临床结果相关,预后不良,可能是复发或转移的潜在预测因子。

相似文献

1
Survivin expression in medulloblastoma: a possible marker for survival.髓母细胞瘤中生存素的表达:一种可能的生存标志物。
Pathol Oncol Res. 2013 Jul;19(3):413-9. doi: 10.1007/s12253-012-9594-9. Epub 2012 Dec 16.
2
Lack of prognostic significance of survivin in pediatric medulloblastoma.存活素在小儿髓母细胞瘤中缺乏预后意义。
Pathol Oncol Res. 2011 Dec;17(4):899-908. doi: 10.1007/s12253-011-9401-z. Epub 2011 Jun 17.
3
Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.髓母细胞瘤中Survivin、Survivin-2B和Survivin-ΔEx3的表达:肿瘤形态学和临床结局的生物学标志物
Br J Cancer. 2005 Jan 31;92(2):359-65. doi: 10.1038/sj.bjc.6602317.
4
Survivin is a negative prognostic marker in medulloblastoma.生存素是髓母细胞瘤的一个负性预后标志物。
Neuropathol Appl Neurobiol. 2005 Aug;31(4):422-8. doi: 10.1111/j.1365-2990.2005.00664.x.
5
Differential expression of survivin splice isoforms in medulloblastomas.髓母细胞瘤中生存素剪接异构体的差异表达。
Neuropathol Appl Neurobiol. 2007 Feb;33(1):67-76. doi: 10.1111/j.1365-2990.2006.00782.x.
6
Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.存活素在儿童髓母细胞瘤中的表达:一种可能的诊断和预后标志物。
In Vivo. 2004 Nov-Dec;18(6):713-8.
7
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.髓母细胞瘤:SHH、WNT 和非 SHH/WNT 分子亚群的临床病理相关性。
Acta Neuropathol. 2011 Mar;121(3):381-96. doi: 10.1007/s00401-011-0800-8. Epub 2011 Jan 26.
8
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.儿童髓母细胞瘤临床样本和实验模型中CD24糖蛋白的异常免疫染色模式。
J Neurooncol. 2015 May;123(1):1-13. doi: 10.1007/s11060-015-1758-5. Epub 2015 Mar 29.
9
[Analysis of pathologic characteristics and prognosis in different subtypes of adult medulloblastoma].[成人髓母细胞瘤不同亚型的病理特征及预后分析]
Zhonghua Bing Li Xue Za Zhi. 2014 Mar;43(3):169-72.
10
Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.钙结合蛋白-D28k在髓母细胞瘤亚群及人髓母细胞瘤细胞系D283 Med中的表达
Arch Pathol Lab Med. 1995 Aug;119(8):734-43.

引用本文的文献

1
Immunoexpression of Survivin and P53 in the Histological Subtypes of Medulloblastoma: A Cross-Sectional Observational Study.髓母细胞瘤组织学亚型中Survivin和P53的免疫表达:一项横断面观察研究。
Cureus. 2024 Jul 29;16(7):e65627. doi: 10.7759/cureus.65627. eCollection 2024 Jul.
2
Targeting the apoptosis pathway to treat tumours of the paediatric nervous system.针对细胞凋亡通路治疗小儿神经系统肿瘤。
Cell Death Dis. 2022 May 14;13(5):460. doi: 10.1038/s41419-022-04900-y.
3
Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells.

本文引用的文献

1
Lack of prognostic significance of survivin in pediatric medulloblastoma.存活素在小儿髓母细胞瘤中缺乏预后意义。
Pathol Oncol Res. 2011 Dec;17(4):899-908. doi: 10.1007/s12253-011-9401-z. Epub 2011 Jun 17.
2
Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors.存活素作为成人和儿童恶性脑肿瘤的免疫治疗靶点。
Cancer Immunol Immunother. 2010 Feb;59(2):183-93. doi: 10.1007/s00262-009-0757-9. Epub 2009 Sep 16.
3
Management of and prognosis with medulloblastoma: therapy at a crossroads.髓母细胞瘤的管理与预后:处于十字路口的治疗
氯唑酰胺与长春新碱联合增强髓母细胞瘤细胞的抗增殖作用。
Gene. 2019 Jul 15;705:67-76. doi: 10.1016/j.gene.2019.04.037. Epub 2019 Apr 13.
4
Survivin expression and serum levels in pancreatic cancer.胰腺癌中Survivin的表达及血清水平
World J Surg Oncol. 2015 May 28;13:189. doi: 10.1186/s12957-015-0605-7.
5
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.托芬那酸在髓母细胞瘤中的抗癌活性:一项临床前研究。
Tumour Biol. 2013 Oct;34(5):2781-9. doi: 10.1007/s13277-013-0836-6. Epub 2013 May 18.
Arch Neurol. 2008 Nov;65(11):1419-24. doi: 10.1001/archneur.65.11.1419.
4
Medulloblastoma: from molecular pathology to therapy.髓母细胞瘤:从分子病理学到治疗
Clin Cancer Res. 2008 Feb 15;14(4):971-6. doi: 10.1158/1078-0432.CCR-07-2072.
5
Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.肿瘤复发部位对复发性或进展性髓母细胞瘤患儿生存的影响。
J Neurosurg. 2007 Jul;107(1 Suppl):5-10. doi: 10.3171/PED-07/07/005.
6
Differential expression of survivin splice isoforms in medulloblastomas.髓母细胞瘤中生存素剪接异构体的差异表达。
Neuropathol Appl Neurobiol. 2007 Feb;33(1):67-76. doi: 10.1111/j.1365-2990.2006.00782.x.
7
Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.髓母细胞瘤的组织病理学预后因素:生存素高表达与不良预后相关。
Eur J Cancer. 2006 Nov;42(17):2996-3003. doi: 10.1016/j.ejca.2006.05.038. Epub 2006 Sep 25.
8
Survivin is a negative prognostic marker in medulloblastoma.生存素是髓母细胞瘤的一个负性预后标志物。
Neuropathol Appl Neurobiol. 2005 Aug;31(4):422-8. doi: 10.1111/j.1365-2990.2005.00664.x.
9
Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.髓母细胞瘤中Survivin、Survivin-2B和Survivin-ΔEx3的表达:肿瘤形态学和临床结局的生物学标志物
Br J Cancer. 2005 Jan 31;92(2):359-65. doi: 10.1038/sj.bjc.6602317.
10
Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.存活素在儿童髓母细胞瘤中的表达:一种可能的诊断和预后标志物。
In Vivo. 2004 Nov-Dec;18(6):713-8.